Ceolus™ and Celphere™: Asahi Kasei Microcrystalline Cellulose Products’ Post

#GlobalBiosimilarWeek Chennupati Indo-American School of Pharmacy #Biosimilars provide a significant opportunity to expand patient access to essential medicines without sacrificing product quality. Data shows that when comparing a biosimilar to its FDA-approved reference product, there are no clinically meaningful differences in safety, purity, or potency. Like all biologics, biosimilars are tested in accordance with the Current Good Manufacturing Practice regulations enforced by the FDA. For more information about the quality, safety, and effectiveness of #biosimilars, view the new educational resource from FDA and US Pharmacopeia: https://lnkd.in/dPRTAbBR 🇺🇸 🎊 🎉 🧬 #CIASP

🌿Exploring the Performance of Low-GWP Propellants🌿As the pharmaceutical industry seeks sustainable solutions, the focus on Low GWP propellants for Pressurized Metered-Dose Inhalers (PMDIs) is growing. The transition represents a significant shift as it involves careful consideration of formulation and inhaler device systems. 🔬 Proveris Laboratories is assisting in this transition with specialized OINDP expertise and technologies for bioequivalence testing. Test services such as cutting-edge INVIDA® In Vitro Inhaled Drug Analysis play a crucial role. By combining human-realistic testing with traditional methods the service reduces risk and accelerates drug products to market. Learn More 📰 Download our technical article: https://lnkd.in/eAJfVh5G 💡 Learn about INVIDA services: https://lnkd.in/eCdSXvGK 🤝 Contact us for expert assistance: https://lnkd.in/eQ_Kfe3 #ProverisLaboratories #TestServices #pMDI #LowGWP #propellants #drugdevelopment #efficiency #LabtoLife

🌟 Lovis 2000 Fuels Innovation in Ophthalmic Drug Formulation 🌟 🔗 Discover how Lovis 2000 transforms quality control in ophthalmic formulations: https://loom.ly/GeVjXd8 A leading multinational pharmaceutical company in India sought an advanced solution for analyzing Newtonian Fluids in their ophthalmic formulations, focusing on hyaluronic acid quality control. By integrating the Lovis 2000 with their existing DMA 4500, they achieved multiparameter measurement for both viscosity and density, enhancing their ability to refine formulations with precision. The Lovis 2000 isn’t just an instrument—it’s a game-changer for pharmaceutical quality control! 👩🏻🔬 #antonpaar #pharma #ophthalmic #viscosity #Lovis2000

Pharmaceutical Technology recently spoke with our SVP of Science & Technology, Parviz A. Shamlou, about the potential impact that the Biosecure Act may have on the pharmaceutical industry, as well as the progress of continuous manufacturing in #biopharma. Parviz shares, “We appreciate that [the Biosecure Act] is an important act designed to protect the health of citizens of this country. And we know we must do everything we can to avoid any unintended, potentially harmful use of our services as highlighted in the act,” says Shamlou. “Abzena has put in place a robust contingency plan as well as a CMC strategy designed to mitigate any such risk to the supply chain and the development of the assets that our customers bring to us.” Click here to listen to the interview: https://lnkd.in/eAMc4fiP #CDMO #CRO #Drugdevelopment #Supplychain

Nitrosamines, a group of chemical compounds known for their carcinogenic properties, have become a major focus for regulators worldwide. For pharmaceutical companies, the stakes couldn’t be higher: 🚫 The presence of nitrosamines can lead to costly recalls, damaging both finances and reputation. 🚫 Insufficient data on nitrosamines can result in approval delays, adding time and expense to the development process. Proactively managing nitrosamine risks is essential for compliance, safety, and maintaining public trust. Solvias is here to help with resources to support your efforts: 🔗 White Paper: The High-Stakes Nature of Nitrosamine Impurities in APIs https://lnkd.in/eJfZ9eHc 🔗 Flyer: New FDA Nitrosamine Impurities Guide - What Drug Developers Need to Know https://lnkd.in/evGKnrHF 🔗 Flyer: The Risk of Nitrosamine Impurities in Biologics - What Biopharma Developers Need to Know https://lnkd.in/eTDDvfyN Download these valuable resources today and stay ahead in your nitrosamine control strategy. #Nitrosamines #NDSRI

🟣 As pharmaceutical manufacturers continue to develop increasingly complex and innovative drug delivery systems, the need for advanced sterility testing solutions is more pressing than ever. 🟣With its rapid turnaround time, robustness, and adaptability, Celsis® Amplified ATP-bioluminescence Rapid Detection offers a compelling solution for companies looking to optimize their testing workflows and ensure the highest standards of product safety and quality. Here are some quick facts about Celsis®rapid microbial detection systems from us this weekend⬇ #celsis #rapid #microbial #detection #RMMs #charlesriver

As pharmaceutical companies strive to maintain competitive margins amidst increasing pressures, Gansons has a solution to offer. Mr. Ashis Banerjee says, Gansons helps clients not only meet current demands but also prepare for future challenges in the ever-evolving pharmaceutical landscape. Pharmaceutical companies are increasingly pressured by rising operational costs, stringent regulatory requirements, and the need for innovation. As a result, maintaining profitability while ensuring high-quality production has become a daunting task. The demand for more efficient processes and cost-effective solutions is at an all-time high. See the video below to learn how Gansons is helping pharmaceutical companies navigate depleting margins. Also if you want to experience the Gansons advantage, Join us at CPHI & PMEC India, Booth No. 9B-06, at India Expo Mart (IEML), Greater Noida, Delhi NCR, from 26th to 28th November 2024  and experience innovation that truly matters. Register at the link below. https://bit.ly/3YmkshE #CPHIIndia #PMECIndia #PharmaEfficiency #PharmaMachinery #GansCoater #TabletCoatingMachine #GranulationEquipment #WetGranulation #FBD #inOne #HighShearMixer #PharmaSolutions #PharmaIndustry #PharmaManufacturing #Exhibition #RDMachine #GansonsGoesOn 

The Solid-State Characterization team at Alcami Corporation possesses the specialized knowledge required to develop and implement crystal form screening strategies, as well as to conduct thorough assessments of new forms of Active Pharmaceutical Ingredients (APIs). Their recent work includes a study that not only identified a new chiral modification of the well-known medication guaifenesin but also provided in-depth characterization and quantification. This significant research was featured in an article in “Crystal Growth and Design,” entitled “Discovery, Characterization, and Solid-State Quantification of the Racemic Compound of Guaifenesin.” A round of applause for Joanna Bis, Briana Graves, Frank Tarczynski, and Lukasz Wojtas for their contributions to this publication! Explore the article here ➡️ https://gag.gl/oLTgQB #SolidStateCharacterization #Crystalformscreening #SolidStateQuantification #Discovery #casestudy #artinspiration #racemiccompound #smallmolecule #crystallization #CDMO #Alcami #research #APIscreening #published

🌟 Bioequivalence Study Workflow as a CRO 🌟 🔬 Dive into the meticulous process of our bioequivalence studies at IBBPS! As a Contract Research Organization (CRO), we ensure every step is precise, efficient, and compliant with global standards. Check out our animated walkthrough to see how we bring accuracy and reliability to every study. 🧪 From initial design to final analysis, our team of experts is dedicated to advancing pharmaceutical research and ensuring the highest quality standards. Discover how we support your journey from development to market. #DUHS #bioequivalence #clinicalresearch #PharmaceuticalSciences #medicalresearch #innovations #healthcare #biopharma #ResearchExcellence #GlobalStandards

Continuous manufacturing of tableted drug products or continuous tableting (CT) represents a paradigm shift in pharmaceutical manufacturing, promising increased efficiency, reduced costs, and accelerated pathways for drug approval. If you are curious to learn more and gain insights into the latest advancements don’t miss the opportunity to hear our expert Sarang Oka at the ConsiGma® Connect event taking place in Mumbai (Oct 22) and Hyderabad (Oct 24). In his session “Challenges and Opportunities in Implementing Continuous Tableting: A CDMO Perspective”, Sarang will share case studies from Hovione's commercial implementation of CT and key learnings from our collaborative work with GEA Pharma & Healthcare including the latest advances on a flexible approach to direct compression and technology simplification.   👉 Learn more about CT and how Hovione ensures the robust transition from development to commercial: - Register for ConsiGma® Connect: https://lnkd.in/ebzF85vK - Meet our team at CPHI India – Delhi, 26-28 Nov - Booth 4.J34:  https://lnkd.in/dcfepY7S - Or ask for a CT meeting today: https://lnkd.in/dhCKNCK2   Hovione – The Future is Continuous   #GEAPharma #continuoustableting #continuousmanufacturing #operationalexcellence #drugproduct #oraldelivery #technology #manufacturing #pharmaceutical #cdmo #initforlife